Valproic acid-exposed astrocytes impair inhibitory synapse formation and function

Sci Rep. 2021 Jan 8;11(1):23. doi: 10.1038/s41598-020-79520-7.

Abstract

Valproic acid (VPA) is widely prescribed to treat epilepsy. Maternal VPA use is, however, clinically restricted because of the severe risk that VPA may cause neurodevelopmental disorders in offspring, such as autism spectrum disorder. Understanding the negative action of VPA may help to prevent VPA-induced neurodevelopmental disorders. Astrocytes play a vital role in neurodevelopment and synapse function; however, the impact of VPA on astrocyte involvement in neurodevelopment and synapse function has not been examined. In this study, we examined whether exposure of cultured astrocytes to VPA alters neuronal morphology and synapse function of co-cultured neurons. We show that synaptic transmission by inhibitory neurons was small because VPA-exposed astrocytes reduced the number of inhibitory synapses. However, synaptic transmission by excitatory neurons and the number of excitatory synapses were normal with VPA-exposed astrocytes. VPA-exposed astrocytes did not affect the morphology of inhibitory neurons. These data indicate that VPA-exposed astrocytes impair synaptogenesis specifically of inhibitory neurons. Our results indicate that maternal use of VPA would affect not only neurons but also astrocytes and would result in perturbed astrocyte-mediated neurodevelopment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticonvulsants / administration & dosage
  • Anticonvulsants / toxicity*
  • Astrocytes / drug effects*
  • Astrocytes / pathology
  • Astrocytes / physiology
  • Cells, Cultured
  • Coculture Techniques
  • Female
  • GABAergic Neurons / drug effects
  • GABAergic Neurons / pathology
  • GABAergic Neurons / physiology
  • Maternal-Fetal Exchange
  • Mice
  • Mice, Inbred ICR
  • Neurons / drug effects
  • Neurons / pathology
  • Neurons / physiology
  • Pregnancy
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptor-Like Protein Tyrosine Phosphatases, Class 2 / genetics
  • Synapses / drug effects
  • Synapses / pathology
  • Synapses / physiology
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology
  • Valproic Acid / administration & dosage
  • Valproic Acid / toxicity*

Substances

  • Anticonvulsants
  • RNA, Messenger
  • Valproic Acid
  • Ptprd protein, mouse
  • Receptor-Like Protein Tyrosine Phosphatases, Class 2